Enovis (ENOV) Cost of Revenue (2010 - 2026)
Enovis' (ENOV) quarterly Cost of Revenue came in at $223.7 million in Q2 2026, down 1.3% year-on-year from $226.6 million in Q2 2025, and down 1.18% on a QoQ basis from $226.3 million in Q4 2025.
Enovis (ENOV) Cost of Revenue (2010 - 2026) Analysis & Trends
Enovis (ENOV) has 17 years of Cost of Revenue data on file, last reported at $223.7 million in Q2 2026.
- On a quarterly basis, Cost of Revenue fell 1.3% year-over-year to $223.7 million in Q2 2026; TTM through Apr 2026 was $899.8 million, a 3.77% decrease from a year earlier, with the FY2025 full-year figure at $902.8 million, down 2.6% from the prior year.
- Cost of Revenue for Q2 2026 stood at $223.7 million, down from $226.3 million in the prior quarter.
- Over the last five years, Cost of Revenue for ENOV reached as high as $253.5 million in Q4 2024 and fell as low as $168.0 million in Q3 2022.
- Historically, Cost of Revenue has averaged $203.7 million across 5 years, with a median of $218.4 million in 2024.
- Across the five-year window, Cost of Revenue tumbled 66.63% in 2022 and soared 32.96% in 2024, its largest moves.
- Year by year, Cost of Revenue stood at $177.0 million in 2022, then climbed by 7.73% to $190.6 million in 2023, then surged by 32.96% to $253.5 million in 2024, then fell by 10.7% to $226.3 million in 2025, then slipped by 1.18% to $223.7 million in 2026.
- Per Business Quant data, the three most recent Cost of Revenue figures were $223.7 million in Q2 2026, $226.3 million in Q4 2025, and $220.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 12.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 362.60 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 441.60 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 481.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2.51 Bn |
| 10 | Enovis | 1.61 Bn | 1.58 Bn | 365.49 Mn | 223.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 223.67 Mn |
| Apr 3, 2026 | 223.67 Mn |
| Dec 31, 2025 | 226.34 Mn |
| Dec 31, 2025 | 226.34 Mn |
| Oct 3, 2025 | 220.00 Mn |
| Oct 3, 2025 | 220.00 Mn |
| Jul 4, 2025 | 229.85 Mn |
| Jul 4, 2025 | 229.85 Mn |
| Apr 4, 2025 | 226.61 Mn |
| Apr 4, 2025 | 226.61 Mn |
| Dec 31, 2024 | 253.46 Mn |
| Dec 31, 2024 | 253.46 Mn |
| Sep 27, 2024 | 218.76 Mn |
| Sep 27, 2024 | 218.76 Mn |
| Jun 28, 2024 | 236.28 Mn |
| Jun 28, 2024 | 236.28 Mn |
| Mar 29, 2024 | 218.37 Mn |
| Mar 29, 2024 | 218.37 Mn |
| Dec 31, 2023 | 190.63 Mn |
| Dec 31, 2023 | 190.63 Mn |